Overview

Dose Finding Study Of CP-870,893, An Immune System Stimulating Antibody, In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumors

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This is a dose-finding study; therefore, there is no hypothesis testing
Phase:
Phase 1
Details
Lead Sponsor:
Hoffmann-La Roche
Treatments:
Albumin-Bound Paclitaxel
Antibodies, Monoclonal
Carboplatin
Paclitaxel